Listeria monocytogenes rhombencephalitis in a patient with multiple sclerosis during fingolimod therapy
ConclusionWe describe the first probable case of fingolimod-associated Listeria monocytogenes rhombencephalitis in a patient with multiple sclerosis. Clinicians should be aware of listeriosis and implement measures for its prevention.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
More News: Gilenya | Hydrocephalus | Listeria | Multiple Sclerosis | Neurology | Shunt for Hydrocephalus | Study